ProCE Banner Activity

IFM 2009: RVD ± Autologous Transplantation in Younger Patients With Newly Diagnosed MM

Slideset Download
Conference Coverage
Results from IFM 2009, which addressed the role of ASCT in the era of effective triplet combination therapy, showed improved PFS and suggest that ASCT in newly diagnosed myeloma should remain a standard of care.

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

Amgen, Inc.

Celgene

Incyte

Merck & Co., Inc.

Millennium Takeda

Seagen